Phosphoinositide 3-kinases in the gut: A link between inflammation and cancer?

Trends in Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 455-462

  Weaver, Sean A ^a   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR;

CELL CYCLE; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; COWDEN SYNDROME; CROHN DISEASE; ENTERITIS; ENZYME ACTIVITY; HUMAN; INTESTINE EPITHELIUM CELL; INTESTINE MOTILITY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; ULCERATIVE COLITIS;

EID: 0034793182     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02107-4     Document Type: Review

References (63)

1. Chronic inflammatory bowel disease and cancer
2. Cancer risk in patients with inflammatory bowel disease
3. Synthesis and function of 3-phosphorylated inositol lipids
4. PI 3-kinase inhibition: A target for drug development?
5. The PI 3-kinase/PDK-1 connection: More than just a road to PKB
6. Cellular survival: A play in three Akts
7. IGF-1 stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways
8. Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle
9. Role of PI 3-kinase in the development of interstitial cells and pacemaking in murine gastrointestinal smooth muscle
10. The tumour suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
11. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease and juvenile polyposis
12. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps with Cowden disease
13. PTEN is essential for embryonic development and tumour suppression
14. Mutation of PTEN/MMAC1 in mice causes neoplasia in multiple organ systems
15. Molecular alterations of the Akt2 oncogene in ovarian and breast carcinomas
16. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
17. Distinct classes of phosphatidylinositol 3-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells
18. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors
19. A specific function for phosphatidylinositol 3-kinase (p85α/p110α) in cell survival and for phosphatidylinositol 3-kinase (p85β/p110β) in de novo synthesis of human colon carcinoma cells
20. Function of PI3Kγ in thymocyte development, T cell activation and neutrophil migration
21. Colorectal carcinomas in mice lacking the catalytic subunit of PI3Kγ
22. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation
23. Roles of PLCβ-2 and β-3 and PI3K in chemoattractant-mediated signal transduction
24. In vitro and in vivo anti-tumor activity of the phosphatidylinositol 3-kinase inhibitor wortmannin
25. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism
26. Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells
27. Activation of PI 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
28. Kip1
29. Kip1 expression
30. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
31. NF-κB is a target of Akt in anti-apoptotic PDGF signalling
32. Up-regulation of cyclooxygenase-2 gene-expression in human colorectal adenomas and adenocarcinomas
33. Specific NFκB blockade selectively inhibits tumour necrosis factor-α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells
34. Regulatory role of phosphatidylinositol 3-kinase on TNFα induced cyclooxygenase 2 expression in colonic epithelial cells
35. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells
36. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia
37. Increased neutrophil receptors for and response to the pro-inflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine
38. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn's disease
39. Roles of phosphatidylinositol 3-kinase and Rac in the nuclear signaling by tumor necrosis factor-α in rat-2 flbroblasts
40. A novel pathway for tumor necrosis factor-α and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase
41. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositol-3-OH kinase-dependent pathway
42. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells
43. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
44. Increased IL-8 expression in the colon mucosa of patients with inflammatory bowel disease
45. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification
46. Activation of NF-κB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase
47. Chemokines in the inflammatory bowel diseases
48. C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: Differential effect of T lymphocyte-derived cytokines
49. Human G-protein coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus expressed chemokine mediated chemotaxis
50. Lymphocyte CC chemokine receptor 9 and epithelial thymus expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue specific chemokines as an organising principle in regional immunity
51. Characterisation of epithelial chemoattractants for human intestinal intraepithelial lymphocytes
52. Regulated production of interferon inducible T cell chemoattractants by human intestinal epithelial cells
53. Phosphoinositide 3-kinase: A key biochemical signal for cell migration in response to chemokines
54. Protein kinases Cγ and -δ are involved in insulin-like growth factor 1-induced migration of colonic epithelial cells
55. Distinct pathways of cell migration and anti-apoptotic response to epithelial injury: Structure-function analysis of human intestinal trefoil factor
56. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis
57. Activation of phosphatidylinositol 3-kinase by interleukin-13: An inhibitory signal for inducible nitric-oxide synthase expression in epithelial, cell line HT-29
58. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: Role of STAT6 and phosphatidylinositol 3′-kinase
59. Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway
60. Impaired B cell development and proliferation in absence of PI3K p85α
61. Xid-like immunodeficiency in mice with disruption of the p85α subunit of PI3K
62. Phosphoinositide 3-kinase activity is required for insulin-stimulated glucose transport, but not for ras activation in CHO cells
63. PI 3-kinase-γ and protein kinaee C-ζ mediate ras-independent activation of MAP kinase by a Gi protein-coupled receptor